Vision
For longevity, your eyes matter mostly in an old-fashioned way. Cataract, glaucoma, diabetic eye disease and macular degeneration are common, treatable and often silent until late, and untreated vision loss goes with a higher risk of dementia. The futuristic part, AI reading your biological age from a photo of your retina, is real science but not yet something to act on. Most eye supplements, clear blue-light glasses and home red-light panels are oversold.
Get a full dilated eye exam by 40, then every one to four years depending on your age and risk, and treat anything correctable promptly: glasses, cataract surgery, glaucoma treatment. Eat leafy greens and eggs, wear certified UV-blocking sunglasses, don't smoke, and take an eye-formula supplement only if an eye doctor has diagnosed intermediate macular degeneration (or advanced disease in one eye).
Why your eyes matter for your brain
Untreated vision loss is now on the official list of modifiable dementia risk factors, but as one of the smaller ones. The 2024 Lancet Commission on dementia found about 50% higher dementia risk with untreated vision loss, slightly more than the 40% for hearing loss. Vision loss is much less common in the Commission's figures (12.7% of people, against 59.0% for hearing loss), so it accounts for only about 2% of dementia cases worldwide, against 7% each for hearing loss and high LDL ("bad") cholesterol.[1]
The case for vision is thinner than the case for hearing. A 2024 study that put a cohort, a meta-analysis and a genetic natural experiment side by side found genetic support for the hearing–dementia link across all dementia and Alzheimer's disease, but for vision only for a residual group of dementias that are neither Alzheimer's nor vascular.[2]
What carries the signal is how badly you see, not which eye disease you have. Macular degeneration by itself is a poor marker of dementia risk: the Commission's own pooling of three studies found no significant link, and the largest test since, across three large health-record networks, found no consistent one.[3] In US health records, blindness raised five-year Alzheimer's risk by about 29%, while the dry form of macular degeneration without blindness did not. The same analysis found the wet form looking mildly protective, a reminder of how much confounding sits in records studies.[4]
No trial has yet tested whether correcting vision protects thinking. The first, a three-year trial of glasses in 760 adults over 60 in India, is still running.[5] The equivalent hearing-aid trial missed its main cognitive endpoint.[6] Correct your vision because it is worth doing today; a brain benefit is a plausible bonus resting on observational data.
Treat hearing loss alongside it. People with both impairments carry roughly 50% higher dementia risk than people with neither, a risk the authors judge to exceed either impairment alone. Whether treating both helps cognition more than treating one has never been tested.[7] See Hearing.
Vision loss also weighs on mood: about 27% of people with macular degeneration screen positive for depression.[8] Against sighted controls the excess is clear for depression but not for anxiety.[9] Rehabilitation and psychological support belong in the treatment plan from the start.
AI eye scans: a real advance, not yet a test for you
The retina is the only place a doctor can look at blood vessels and nerve tissue without cutting, and AI models can now read ordinary retinal photos to estimate age, heart risk and even risk of death. This is genuine research, but none of it is validated or endorsed for screening healthy adults, and some of it is still unreviewed preprints.
Retinal age is the best-known example. In nearly 36,000 UK Biobank participants, each year by which the "retinal age" exceeded real age went with a 2% higher death rate, a small signal whose confidence range reaches down to no effect at all.[10] Retinal blood-vessel measurements also track stroke risk, but adding them to standard risk factors barely improved prediction.[11]
Two problems keep these tools out of routine care. They travel badly: a model trained on Japanese adults predicted age to within about 3 years in Japanese data but was off by 8.63 years in a UK hospital dataset.[12] And one person's number is noisy: photographing the same eye twice in one sitting shifted the predicted age by about 2 years on average, and between two visits by up to about 9 years.[13] An OCT scan (a cross-section of the retina) is worth having if it is offered as part of a full exam. There is no reason to seek out an AI ageing-clock reading.
Cataract and glaucoma: the fixable ones
Cataract, a clouding of the lens, causes about 40% of the world's blindness.[14] Smoking, diabetes, steroid tablets and inhalers, alcohol and sunlight raise the risk. The sunlight link is clearest for one subtype, and exposure is measured poorly across this literature.[15] Certified UV-blocking sunglasses are a cheap hedge.
Cataract surgery does more than sharpen your sight. In a randomised trial of 306 women over 70, having the first eye done within about four weeks instead of a year cut the rate of falls by about a third and fractures from 8% to 3%. The share who fell at least once did not change; the gain was in repeat falls.[16] A smaller trial of second-eye surgery saw a very similar drop in falls that did not reach statistical significance. Its authors called the effect uncertain rather than absent, and the operation still improved depth perception and confidence, so it is no reason to skip the second eye.[17]
The dementia link is weaker. One cohort of about 3,000 older adults found 29% lower dementia risk after cataract surgery, with residual confounding the live worry.[18] Later pooling went both ways: one meta-analysis found 25% less long-term cognitive decline at very low to low certainty,[19] while another, of over 700,000 people, found no significant link with all-cause dementia.[20] There are no randomised data.
Glaucoma damages the optic nerve with no symptoms until it is advanced, and the vision it takes does not come back. Eye pressure is the only major risk factor you can change. Risk is higher with age, a family history, Black or Hispanic/Latino ancestry, high short-sightedness and diabetes.
Laser is now a first-line treatment, not just a fallback. In a trial of 718 newly diagnosed people, a quick outpatient laser (selective laser trabeculoplasty) left 74% needing no drops at three years, and no one in the laser arm needed glaucoma surgery, against 11 people on drops.[21] At six years about 70% of laser-treated eyes were still at target pressure without drops or surgery, with less disease progression and fewer operations, though quality of life, the extension's main outcome, did not differ.[22] The US Preventive Services Task Force found the evidence insufficient to recommend population glaucoma screening, so glaucoma is found within a full eye exam rather than by a standalone test.[23]
Exercise lowers eye pressure for a while afterwards, about twice as much in sedentary people as in fit ones, but there is little evidence it prevents glaucoma.[24] One caution for lifters: in 20 healthy young adults, holding the breath through a heavy repetition raised eye pressure substantially more than breathing normally, most on big compound lifts. Whether that matters clinically is untested, but if you have glaucoma or high eye pressure, raise your lifting technique with your eye doctor.[25]
Dry eye, short sight and diabetes
Dry eye becomes common with age and in women: about 7% of US adults have a diagnosis, rising to nearly 19% at 75 and over.[26] Fish oil does not help: the large DREAM trial gave 3,000 mg a day and found it no better than placebo.[27] Screens make it worse mainly because your blinks become less complete, and during demanding tasks less frequent.[28] The 20-20-20 rule (every 20 minutes, look about 6 metres away for 20 seconds) is a clinical convention, and its one controlled test, in 30 adults over a single 40-minute session, found no effect.[29] Use it as a free prompt to blink; lid hygiene, artificial tears and finding the underlying cause do the real work. Short breaks have the better evidence; see Vision decline with age.
Short sight (myopia) in children is best prevented outdoors, on moderate-certainty randomised evidence. Adding 40 minutes of outdoor school time a day cut new cases over three years from about 40% to 30%.[30] A Cochrane review pooling three trials found about 16% fewer new cases at two years, with the effect mainly on onset rather than on how fast existing myopia worsens.[31] For a child already short-sighted, low-dose atropine drops and special lenses slowed progression in short, mostly low-certainty trials, and what happens after treatment stops is unclear; that is a conversation with a children's eye specialist.[32] Adults with high myopia face more retinal detachment, macular damage and glaucoma, and should be examined more often.
Diabetic eye disease is a blood-sugar problem showing up in the eye. In type 1 diabetes, intensive control cut new retinopathy by 76% and slowed its progression by 54% over about six and a half years, at the cost of two to three times more severe hypos.[33] In type 2 the benefit is smaller: retinopathy progressed in 7.3% of intensively treated people against 10.4% over four years. That trial's intensive-glucose arm was stopped early for excess deaths among people at high cardiovascular risk, so "tighter is better" is not unconditional advice for an older adult with heart disease.[34] The eye benefit lasted years after the trial ended (5.8% against 12.7% progression).[35] Large, rapid drops in blood sugar can temporarily worsen retinopathy before the long-term benefit appears, so have a retinal exam before starting insulin, a GLP-1 drug or bariatric surgery.[36] See GLP-1 receptor agonists and Metabolic flexibility.
Lutein and the eye formula: who actually needs a supplement
Lutein and zeaxanthin are yellow pigments from leafy greens and egg yolks that collect in the macula, the centre of the retina, where they filter incoming short-wave light. Higher levels go with faster visual processing and better contrast sensitivity and glare recovery in healthy adults. Typical US intake is 1–2 mg a day, well below the 6–12 mg range linked with benefit.[37]
Food gets you there easily. A cup of cooked spinach has about 20 mg (about 30 mg from frozen) and cooked Swiss chard about 19 mg; cooked kale has only about 6 mg a cup.[38] Egg yolk lutein is well absorbed, and orange and yellow peppers and corn supply zeaxanthin.
The supplement with real evidence is the AREDS formula (antioxidant vitamins, zinc, copper, and now lutein and zeaxanthin). In people with intermediate macular degeneration, or advanced disease in one eye, it cut progression to advanced disease by about a quarter: a 20% five-year chance of progressing, against 28% on placebo.[39] In early disease the five-year risk was just 1.3%, too low for any benefit to show, and healthy eyes were never studied, so the formula has never been tested as prevention.[40] The 2023 Cochrane review agrees that the full formula probably slows progression in intermediate disease.[41]
The second trial, AREDS2, swapped beta-carotene for lutein and zeaxanthin, because beta-carotene had been linked to lung cancer in smokers, so avoid the older beta-carotene version. It also found 25 mg of zinc worked as well as 80 mg with no difference in side effects, so there is no reason to seek out high-zinc products. Adding lutein gave no significant extra benefit in the main analysis; its value is as the safer swap.[42]
Lutein pills have no proven benefit for the brain or for ageing. The largest test of lutein for thinking, the AREDS2 cognition study in more than 3,000 older adults with macular degeneration and at risk of its advanced form, found no significant effect.[43] The positive results come from two small trials of 51 people each by one research group,[44][45] and pooled analyses split. The idea that lutein slows ageing in the whole body rests on one survey analysis whose roughly 40% lower mortality is far too large for one pigment and most likely healthy-eater confounding.[46] Eat the greens; don't expect a lutein pill to sharpen your mind.
Red light: a clinic treatment, not a home gadget
Red light therapy rests on a real mechanism: the retina loses roughly 70% of its cellular energy output over a lifetime,[47] and deep-red light at 670 nm is absorbed by an enzyme in mitochondria, the cell's power plants.[48] In people, the evidence for home devices is thin. In 20 adults aged 38–70, a single three-minute morning exposure improved colour-contrast vision by about 12–17%,[49] while a 12-month pilot with no control group, at five times the dose, found no structural or functional benefit in 31 people with intermediate macular degeneration.[50] Consumer panels vary widely in output and purity, and long-term outcomes are unknown. Plausible and low-risk; not proven.
Clinic-delivered light, using three wavelengths in short courses repeated every four months, is a different treatment with better evidence. In a double-masked, sham-controlled trial of 100 people with dry macular degeneration, 6.8% of treated eyes had progressed to the advanced "geographic atrophy" stage by 24 months, against 24.0% of sham-treated eyes.[51] A second sham-controlled trial found drusen, the deposits of the disease, shrinking on treatment while they grew on sham.[52] The US Food and Drug Administration authorised the device in November 2024. Both trials have industry ties and neither has long-term independent replication. If you have intermediate dry macular degeneration, it is worth raising with a retina specialist. It is still no reason to buy a home panel.
Blue light: skip the clear glasses
Blue-light glasses are marketing ahead of the evidence. The 2023 Cochrane review of 17 small, short trials found they probably make little or no difference to sharpness of vision and may not ease eye fatigue; it could not tell whether they affect sleep, and found no randomised evidence on macular health.[53]
For scale, a phone or tablet at full brightness gives roughly 0.1–0.4% of the international safety limit for blue light, against about 10% for looking at a sunny blue sky.[54] The American Academy of Ophthalmology says there is "no scientific evidence that blue light from digital devices causes damage to your eye" and does not recommend blue-blocking eyewear for computer use, while noting that blue light's effects are still being researched.[55]
Strong deep orange filters are a different product: the clear and near-clear lenses sold for screens fall below the bar for blocking the light that sets your body clock, while glasses that clear it, worn in the hours before bed, improved at least one sleep or body-clock measure in each of 16 field studies; two of the paper's five authors work for a blue-light-filtering software company.[56] Even so, morning daylight and dimming the lights in the evening are stronger levers. See Circadian rhythms and Sun exposure.
Saffron and other "eye supplements"
Saffron, usually 20–30 mg a day, is the most promoted, and its trials are too few, small and varied to pool.[57] The largest randomised trial, in 100 people with macular degeneration, found a gain of 0.69 letters, well under one line on the eye chart,[58] and the review making the case for it comes from the group behind most of the trials, with a first author affiliated with a saffron company.[59] None of this is a reason to add saffron to established care.
CoQ10, NAD+ boosters (NMN, NR) and resveratrol are sometimes sold for eye health on mitochondrial grounds, but none has meaningful outcome data in the retina. Judge them on the general supplement evidence.
Everyday habits that help your eyes
Exercise. A review of 21 studies found aerobic training shifted retinal vessels towards the healthier pattern, and twelve weeks of interval training improved how well they dilate in older people with cardiovascular risk factors.[60] In nearly 43,000 people with type 2 diabetes, more physical activity went with less moderate and severe retinopathy, and the study's follow-up arm found about 19% lower risk of developing it.[61] In people with glaucoma, three months of aerobic training lowered resting eye pressure by about 4.6 mmHg.[62] Across ten cohorts of 1.9 million people, the most active had about 10% less cataract than the least active, a modest, observational link; for macular degeneration the difference was smaller and could be chance.[63] See Zone 2.
Smoking and sunlight. Smoking is a large independent risk factor for macular degeneration, and chronic UV exposure for cataract. The benefit of quitting builds slowly: in 44,371 Swedish men, heavy smokers who had quit more than 20 years earlier were still about 21% more likely to need cataract surgery than never-smokers.[64] Quit, and wear certified UV-blocking sunglasses on bright days; a cheap certified pair is fine.
Sleep and body clock. The retina runs its own daily clock; in flies, disrupting it causes retinal degeneration.[65] In humans the evidence is only associative: people with macular degeneration report later sleep timing and worse mornings.[66]
Fasting. Intermittent fasting protected the retina against a chemical injury in mice.[67] In people over 60, observational data link eating windows of 10 hours or less with worse outcomes, including lower cognitive scores, and overnight fasts longer than about 12.4 hours with 58% higher cardiovascular mortality, which would put 16:8 inside the band of concern. The authors call this hypothesis-generating.[68] See Fasting.
When your eyes change at 40
From your mid-40s nearly everyone loses close-up focus, and contrast, glare and night vision decline in ways an eye chart misses. None of this is disease, and eye exercises don't reverse it. What does help, from reading glasses and eye drops to lighting and night-driving habits, is covered in Vision decline with age.
When to get same-day care
Some eye symptoms cannot wait for a routine appointment. Get seen the same day, by an eye doctor or an emergency department, for:
- A shower of new floaters, flashes of light, or a dark shadow or "curtain" across your vision. These are the signs of a retinal tear or detachment, which the US National Eye Institute calls a medical emergency.[69][70] The gel inside the eye usually pulls away from the retina somewhere between 45 and 65, which is why new floaters are common in midlife and usually harmless.[71] But about 1 in 7 people who get sudden new floaters or flashes checked turn out to have a retinal tear.[72]
- Sudden loss or blurring of vision in one eye, even without pain. A blocked artery in the retina is a form of stroke and a medical emergency.[73] On semaglutide, sudden vision loss can also come from a stroke of the optic nerve; see GLP-1 receptor agonists.
- A painful red eye with blurred vision, rainbow-coloured rings around lights, headache or nausea. This can be sudden glaucoma, which the NHS treats as an emergency.[74]
- Straight lines looking wavy or crooked. This is a warning sign of late macular degeneration; see your eye doctor right away.[75]
How often to get your eyes examined
For adults without symptoms or risk factors, the American Academy of Ophthalmology advises an exam every 2–4 years from 40 to 54, every 1–3 years from 55 to 64, and every 1–2 years from 65. Tighten each band by one step (1–3 years at 40–54, 1–2 years at 55–64) if you have a family history of glaucoma, Black or Hispanic/Latino ancestry, or high myopia.[76] With diabetes, get an exam at diagnosis for type 2, five years after onset for type 1, and at least yearly after that.[77]
Ask for a full dilated exam, which checks for cataract, glaucoma, diabetic retinopathy and macular degeneration. A quick sight test for glasses does not.
Further reading
- Livingston G et al. Dementia prevention, intervention, and care: 2024 report of the Lancet Standing Commission. Lancet 2024.[78]
- Zhu Z et al. Retinal age gap as a predictive biomarker for mortality risk. British Journal of Ophthalmology 2023.[79]
- Grimbly MJ et al. Estimating biological age from retinal imaging: a scoping review. BMJ Open Ophthalmol 2024.[80]
- Stringham JM et al. Lutein across the Lifespan: From Childhood Cognitive Performance to the Aging Eye and Brain. Curr Dev Nutr 2019.[81]
- Evans JR, Lawrenson JG. Antioxidant vitamin and mineral supplements for slowing the progression of age-related macular degeneration. Cochrane Database of Systematic Reviews 2023.[82]
- Chew EY et al. Effect of omega-3 fatty acids, lutein/zeaxanthin, or other nutrient supplementation on cognitive function: the AREDS2 randomized clinical trial. JAMA 2015.[83]
- Harwood RH, Foss AJE et al. Falls and health status in elderly women following first eye cataract surgery: a randomised controlled trial. British Journal of Ophthalmology 2005.[84]
- Lee CS et al. Association between cataract extraction and development of dementia. JAMA Internal Medicine 2022.[85]
- Gazzard G et al. Laser in Glaucoma and Ocular Hypertension (LiGHT) Trial: six-year results of primary selective laser trabeculoplasty versus eye drops. Ophthalmology 2023.[86]
- Asbell PA et al. n-3 fatty acid supplementation for the treatment of dry eye disease (DREAM). New England Journal of Medicine 2018.[87]
- He M et al. Effect of time spent outdoors at school on the development of myopia among children in China: a randomized clinical trial. JAMA 2015.[88]
- Singh S et al. Blue-light filtering spectacle lenses for visual performance, sleep, and macular health in adults. Cochrane Database of Systematic Reviews 2023.[89]
- Shinhmar H et al. Weeklong improved colour contrasts sensitivity after single 670 nm exposures associated with enhanced mitochondrial function. Scientific Reports 2021.[90]
- Maggi MA et al. Saffron as a retinal neuroprotectant: a narrative review of preclinical studies and clinical results. Antioxidants (Basel) 2026. Written by the trial group itself, with a first author affiliated to the saffron company whose patented preparation the review promotes.[91]